Sentinel Node Mapping in Patients with Malignant Melanoma Using Melanoma Tc-99m Colloidal Rhenium Sulfide

Weiss, Mayo; Kunte, Christian; Schmid, Rupert; Konz, Birger; Dresel, S.; Hahn, Klaus

doi:10.1097/01.rlu.0000063986.65440.13

Cited by 8 publications

(5 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…How to precisely locate SLNs in different parts of the body has become an important question in recent years. The injection of radioactive tracers coupled with intraoperative γ probe detection of SLNs is clinically useful, but it is not used in clinical settings because radioactive elements are involved and expensive instruments are needed 31–33 . The dye method is safe, but the effects of blue dyes, such as methylene blue, are poor, and the learning curve of clinicians is long.…”

Section: Discussionmentioning

confidence: 99%

The Value of Contrast‐Enhanced Ultrasound in the Detection of Sentinel Lymph Nodes in Malignant Melanoma

Deng

et al. 2022

J of Ultrasound Medicine

View full text Add to dashboard Cite

Objective To evaluate the location and characterization value of contrast‐enhanced ultrasound (CEUS) in the detection of sentinel lymph nodes (SLNs) in malignant melanoma. Methods SLNs and the lymph node network were tracked by subcutaneous injection of ultrasonic contrast agent around the tumor and preoperative localization, and qualitative analyses were performed. The SLNs were also detected by the intraoperative subcutaneous injection of carbon nanoparticles, and the findings were compared with lymph nodes located by CEUS. The accuracy of the preoperative lymph node identification was evaluated by the results of postoperative pathology, which served as the gold standard of detection. Results In 47 patients with malignant melanoma, the mean number of SLNs detected by CEUS was 1.72 ± 0.10, while that by carbon nanoparticle administration it was 1.79 ± 1.07 (P = .371 > .05). Seven cases of lymph node metastasis were detected by CEUS, with a sensitivity of 70.0%, specificity of 97.3%, positive predictive value of 87.5%, negative predictive value of 92.3%, and accuracy of 91.5%. There was high consistency between the findings of CEUS and pathology in differentiating benign and malignant lymph nodes (kappa = 0.726, χ2 = 25.243, P < .001). Conclusions CEUS can localize and differentiate SLNs in malignant melanoma, and thus, may potentially guide clinical treatment in the future.

show abstract

Section: Discussionmentioning

confidence: 99%

The Value of Contrast‐Enhanced Ultrasound in the Detection of Sentinel Lymph Nodes in Malignant Melanoma

Deng

et al. 2022

J of Ultrasound Medicine

View full text Add to dashboard Cite

show abstract

“…Moreover, its biocompatibility allows ReS 2 to be widely utilized in clinical and biomedical fields. [70][71][72] Recently, Xu et al explored the application of ReS 2 serving as theranostic agent for cancer therapy, and obtained an excellent photothermal conversion of 79.2%. 73 This feature renders ReS 2 to realize a tumor elimination of 100% when being used for photothermal ablation.…”

Section: Other Applicationsmentioning

confidence: 99%

Novel Insights and Perspectives into Weakly Coupled ReS2 toward Emerging Applications

Zhang

2019

Chem

View full text Add to dashboard Cite

The rise of transition-metal dichalcogenide (TMD) materials has enormous implications for the scientific community and beyond. Among TMDs, ReS 2 has received significant attention regarding its extraordinary properties in all fields during the past 5 years. Most notably, the weak interlayer coupling feature enables bulk ReS 2 to behave as electronically and vibrationally decoupled monolayers, leading to an obvious layer-independent character in various properties. Because of the extremely weak interlayer coupling, it renders ReS 2 to be well utilized without precise control in layer numbers. Here, from the perspective of weak interlayer coupling, recent advances in the emerging applications of ReS 2 , including rechargeable batteries, catalytic reactions, stimuli-responsive devices, and other applications, are discussed in detail. We conclude by discussing novel insights into weakly coupled ReS 2 for various applications and analyze the possible future orientations in the exploration of unusual properties and applications.

show abstract

“…номер ЛС-002365), который готовится ex temporo на основе стандартного набора «Технефит 99mTc» и элюата, по-лученного из генератора технеция-99m. Радиоактивный коллоид «Технефит 99mTc» активностью 75-200 МБк вво-дится по периметру опухоли: · При меланоме кожи туловища и конечностей -внутри и подкожно, отступая от видимой границы опухоли на 5-10 мм; при инфильтрации тканей вокруг опухоли инъ-екции коллоида производятся, отступая на 10-15 мм от видимых границ инфильтрации [11]. · При раке молочной железы -внутри и подкожно на рас-стоянии 1-2 мм от границ опухоли.…”

Section: методика исследованияunclassified

Sentinel lymph nodes biopsy in early breast cancer and melanoma patients using “Tehnefit 99mTc” radioactive colloid technetium 99mTc

Ермаков¹,

Зикиряходжаев²,

Лазутина³

et al. 2016

Zlokač. opuholi

View full text Add to dashboard Cite

Sentinel Node Mapping in Patients with Malignant Melanoma Using Melanoma Tc-99m Colloidal Rhenium Sulfide

Abstract: The findings indicate that Tc-99m-bound colloidal rhenium sulfide is suitable for sentinel node mapping.

Cited by 8 publications

References 22 publications

The Value of Contrast‐Enhanced Ultrasound in the Detection of Sentinel Lymph Nodes in Malignant Melanoma

The Value of Contrast‐Enhanced Ultrasound in the Detection of Sentinel Lymph Nodes in Malignant Melanoma

Novel Insights and Perspectives into Weakly Coupled ReS2 toward Emerging Applications

Sentinel lymph nodes biopsy in early breast cancer and melanoma patients using “Tehnefit 99mTc” radioactive colloid technetium 99mTc

Contact Info

Product

Resources

About